Press Release Primmune Therapeutics Secures $22.5 Million Contract from Defense Threat Reduction Agency (DTRA) to Advance PRTX007 for Treatment of Lassa Fever
Press Release Bristol Myers Squibb Announces CheckMate -9DW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Meets Primary Endpoint of Overall Survival for the First-Line Treatment of Advanced Hepatocellular Carcinoma
Press Release Chemours and Partners Selected for $60M in U.S. Department of Energy Grants to Support Continued Advancement of Global Hydrogen Economy
Press Release Babcock & Wilcox Receives Contracts Totaling $24 Million for Three Middle East Industrial Boilers
Press Release PocketHealth Raises $33M USD in Series B Funding to Transform Medical Image Exchange and Patient Experience
